News and Events Archive

Mentoring the Next Generation of Life Science Innovators

Blog, Jonathan Gertler PostsBack Bay Life Science AdvisorsAugust 3, 2018Mentoring, Startup

Princeton University Graduate Consulting Club Case Competition

EventsJocelyn MillerJune 11, 2018Graduate Consulting Club, Princeton University

Back Bay at Annual meeting of the American Society of Clinical Oncology (ASCO)

EventsBack Bay Life Science AdvisorsJune 10, 2018ASCO, Cancer, Oncology

Back Bay Welcomes the BIO International Convention to Boston

EventsBack Bay Life Science AdvisorsJune 10, 2018BIO Innovation, BIO International Convention

Neoantigen-Based Cancer Immunotherapy: One Step Closer to the Promise of Personalized Medicine

WhitepapersPeter Bak, PhDJune 3, 2018ASCO, Cancer, Check Point Inhibitors, immuno-oncology, Neoantigens, Oncology

Back Bay Report on Neoantigen-Based Cancer Immunotherapy

Blog, Jonathan Gertler Posts, Michelle Hoffmann Posts, Peter Bak Posts, WhitepapersBack Bay Life Science AdvisorsJune 3, 2018ASCO, Cancer, CART-T, immuno-oncology, Neoantigens, Oncology, T Cell, White Paper

Asia Opens Its Doors for Pre-Revenue Biotechs

Blog, Team PostsInvestment Banking TeamMay 29, 2018Biotech

Transcatheter Mitral Valve Technologies: The Heart of Cardiovascular Device Innovation

News, WhitepapersBack Bay Life Science AdvisorsMay 16, 2018Cardiovascular Technology, healthcare, White Paper

Back Bay CEO Selected as Judge for BIO 2018 Start-Up Stadium

Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsMay 8, 2018

Bloomberg Radio Interview: Danish-American Partnering and Life Sciences Development

Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsMay 8, 2018Bloomberg, Jonathan Gertler, Radio Interview

2018 Transactional Trends: Key Issues for Cross-Border Deals; Focus on Emerging and Mid-Size Companies

Blog, Greg Benning PostsInvestment Banking TeamMay 2, 2018Harvard Medical School, Investment, Transactions

Back Bay Life Science Advisors to Lead Fireside Chat with Myovant Sciences President & Chief Executive Officer, Lynn Seely at Convergence Forum 2018

Events, Jonathan Gertler Postsjonathan gertlerApril 24, 2018Convergence Forum, Jonathan Gertler, Myovant

Back Bay Celebrates 8 Years and 450 Life Science Assignments

Blog, Jonathan Gertler Posts, Newsjonathan gertlerApril 2, 2018Biotech, cross-border, Denmark, healthcare, Jonathan Gertler, Wall Street Journal, WSJ

Danish Life Science Leaders and US Investors to Meet on Cross-Border Development

Events, featured, NewsBack Bay Life Science AdvisorsMarch 28, 2018Biotech, DKBIO2018, Life sciences seminar

Xconomy: Proxima Aims to Fill CRO Gap for Houston’s Growing Biotech Community

Jonathan Gertler Posts, News, Back Bay in the Newsjonathan gertlerMarch 14, 2018Biotech, healthcare, Jonathan Gertler, Wall Street Journal, WSJ

Life Science Leader: Dynamics and Value of Cross-Border Biotech

Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsMarch 1, 2018Biotech, cross-border, Denmark, healthcare, Jonathan Gertler, Wall Street Journal, WSJ

STAT: Biosimilars, The Cure for Sky-High Drug Prices or a Stake in the Heart of Innovation?

Michelle Hoffmann Posts, NewsBack Bay Life Science AdvisorsFebruary 9, 2018Biosimilars, Biotech, Michelle Hoffmann

What Should Be Done About the Shrinking Number of US Public Companies?

Blog, Greg Benning Posts, NewsInvestment Banking TeamFebruary 6, 2018Finance, Greg Benning, JP Morgan, JPM, Public companies

Fierce CEO: Back Bay Life Science Advisors CEO Helps Healthcare Companies Grow

featured, Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsJanuary 29, 2018Biotech, healthcare, Jonathan Gertler, Wall Street Journal, WSJ

White Paper: US Biosimilars 2018: Opportunities and Challenges

News, WhitepapersBack Bay Life Science AdvisorsJanuary 3, 2018Biotech, healthcare, Jonathan Gertler, Wall Street Journal, WSJ